You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antisense oligonucleotides

Showing 1 - 25 of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Duchenne Muscular Dystrophy Trial in London (AVI-4658 (PMO))

Completed
Has Results
  • Duchenne Muscular Dystrophy
  • AVI-4658 (PMO)
  • London, United Kingdom
    Dubowitz Neuromuscular Centre, Hammersmith Hospital and Clinical
Nov 18, 2019

Acute Coronary Syndrome, Lipoproteinemia, Inflammation Trial in Ljubljana (Pelacarsen (TQJ230), Placebo)

Withdrawn
  • Acute Coronary Syndrome
  • +3 more
  • Pelacarsen (TQJ230)
  • Placebo
  • Ljubljana, Slovenia
    University Medical Centre Ljubljana-Department of Vascular disea
Dec 10, 2021

Duchenne Muscular Dystrophy Trial in Tokyo, Hyogo, Kobe-shi (DS-5141b)

Active, not recruiting
  • Duchenne Muscular Dystrophy
  • Tokyo, Kodaira-Shi, Japan
  • +1 more
Mar 2, 2022

Multiple Myeloma, Refractory, Hepatocarcinoma, Advanced Solid Tumor Trial in Catanzaro (LNA-i-miR-221)

Completed
  • Multiple Myeloma, Refractory
  • +2 more
  • LNA-i-miR-221
  • Catanzaro, Italy
    Center for Phase I Clinical Studies in Medical Oncology and Onco
Jan 31, 2022

Primary IgA Nephropathy Trial (RO7434656, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • (no location specified)
Mar 22, 2023

Healthy Volunteers Trial in Toronto (ION547, Placebo)

Completed
  • Healthy Volunteers
  • Toronto, Ontario, Canada
    BioPharma Services, Inc.
Sep 21, 2022

Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

Recruiting
  • Mantle Cell Lymphoma
  • +9 more
  • L-Bcl-2 antisense oligonucleotide
  • Augusta, Georgia
  • +2 more
Nov 18, 2022

Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))

Recruiting
  • Duchenne Muscular Dystrophy
  • Phase 1, SQY51
  • +3 more
  • Garches, France
    Hôpital Raymond Poincaré
Mar 7, 2023

Quantification of Antisense HIV RNA in Patients

Recruiting
  • HIV-1-infection
  • Blood sampling
  • Paris, France
    Jean-Paul VIARD
Dec 21, 2022

Duchenne Muscular Dystrophy Trial in Hyogo, Tokyo (DS-5141b)

Completed
  • Duchenne Muscular Dystrophy
  • Hyogo, Kobe-shi, Japan
  • +1 more
Dec 14, 2020

Spinal Muscular Atrophy Trial in Praha (Individual physiotherapy (SMA-SOC), Hippotherapy, Therapeutic grooming)

Recruiting
  • Spinal Muscular Atrophy
  • Individual physiotherapy (SMA-SOC)
  • +2 more
  • Praha, Czechia
    Kamila Řasová
Sep 13, 2022

Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)

Not yet recruiting
  • Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
  • XELOX combined with Fruquintinib and Sintilimab
  • (no location specified)
Oct 17, 2023

Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)

Completed
Has Results
  • Bladder Cancer
  • Urothelial Carcinoma
  • Birmingham, Alabama
  • +34 more
Jul 7, 2022

Healthy Participants Trial in Toronto (IONIS FXI-LRx, Placebo)

Completed
  • Healthy Participants
  • IONIS FXI-LRx
  • Placebo
  • Toronto, Ontario, Canada
    BioPharma Services Inc.
Jan 13, 2022

Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

Completed
  • Rheumatoid Arthritis
  • ISIS 104838
  • Birmingham, Alabama
  • +30 more
Dec 1, 2022

Cystic Fibrosis, CFTR Gene Mutation Trial in Montpellier (Nasal cells sampling, Rectal biopsy sampling)

Recruiting
  • Cystic Fibrosis
  • CFTR Gene Mutation
  • Nasal cells sampling
  • Rectal biopsy sampling
  • Montpellier, France
    Montpellier University Hospital
Mar 31, 2022

Covid19 Trial in Rio De Janeiro, São Paulo (ISIS 721744, Normal Saline)

Completed
  • Covid19
  • ISIS 721744
  • Normal Saline
  • Rio De Janeiro, Brazil
  • +2 more
Sep 21, 2022

Antisense Oligonucleotide for Spinal Muscular Atrophy

Recruiting
  • Spinal Muscular Atrophy
  • Beijing, Beijing, China
  • +2 more
Jan 11, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (BP1002; Liposomal Bcl-2 Antisense

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide
  • Decitabine (in combination with BP1002)
  • (no location specified)
Mar 8, 2022

Facioscapulohumeral Muscular Dystrophy Trial in Nice (Validation of new COMs for non ambulant FSHD patients)

Not yet recruiting
  • Facioscapulohumeral Muscular Dystrophy
  • Validation of new COMs for non ambulant FSHD patients
  • Nice, Alpes Maritimes, France
    CHU de Nice
Jul 11, 2022

Crohn's Disease Trial in Canada, United States (Alicaforsen)

Completed
  • Crohn's Disease
  • Little Rock, Arkansas
  • +29 more
Dec 1, 2022

Ulcerative Colitis Trial in Chicago (Alicaforsen)

Completed
  • Ulcerative Colitis
  • Chicago, Illinois
    (unnamed)
Dec 1, 2022

Crohn's Disease Trial in Worldwide (Alicaforsen)

Completed
  • Crohn's Disease
  • Kortrijk, Belgium
  • +15 more
Aug 11, 2022

Ulcerative Colitis Trial in Sacramento (Alicaforsen)

Completed
  • Ulcerative Colitis
  • Sacramento, California
    (unnamed)
Dec 1, 2022

Dyslipidemias, Hyperlipidemias, Hyperlipoproteinemias Trial in Canada, Poland, United States (Vupanorsen, Placebo)

Completed
  • Dyslipidemias
  • +2 more
  • Gilbert, Arizona
  • +112 more
Jan 6, 2022